Relating to discriminatory practices by a health benefit plan issuer, pharmacy benefit manager, and third-party payor and certain prescription drug manufacturers, distributors, and related persons with respect to certain entities participating in a federal drug discount program; providing a civil penalty.

HB 3265 prohibits health benefit plan issuers, pharmacy benefit managers, and drug manufacturers from discriminating against entities participating in the federal 340B drug discount program. It bans denying access to discounted drugs, restricting acquisitions, or requiring unnecessary data submission as a condition for 340B drug access. Covered entities (like community health centers and hospitals), pharmacies under contract with them, and their authorized partners are directly protected. Violations carry a civil penalty of up to $50,000 per offense, enforceable through the Texas Health and Human Services Commission.